Inhaler
Latest Novartis AG Patents:
- Injection device and injection solution transferring system
- ANTI-IgE ANTIBODY THERAPY FOR MULTIPLE FOOD ALLERGIES
- Crystalline forms of -(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as Raf inhibitors for the treatment of cancer
- Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy
- Anti-CCR7 antibody drug conjugates
Description
Claims
The ornamental design of an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D579544
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Oct 28, 2008
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: John W. Kung
Application Number: 29/292,805
Type: Grant
Filed: Oct 29, 2007
Date of Patent: Oct 28, 2008
Assignee: Novartis AG (Basel)
Inventors: Martin Birath (Stockholm), Hans Himbert (Stockholm), Sofia Jacobsson (Bromma), Thomas Nilsson (Bromma), Ulrika Vejbrink (Hägersten)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: John W. Kung
Application Number: 29/292,805
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)